Reuters logo
BRIEF-VBI Vaccines announces proposed concurrent public offering
October 25, 2017 / 8:13 PM / in 2 months

BRIEF-VBI Vaccines announces proposed concurrent public offering

Oct 25 (Reuters) - VBI Vaccines Inc:

* VBI Vaccines announces proposed concurrent public offering and registered direct offering of common shares

* VBI Vaccines- to use proceeds from offerings to fund pivotal phase III clinical program for SCI-B-VAC in U.S., Europe, Canada​

* VBI Vaccines Inc - ‍ to also use proceeds from offerings for funding phase I/IIA clinical study of VBI-1901 for glioblastoma multiforme, among others Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below